$DVAX
DYNAVAX TECHNOLOGIES CORP

2018 Q1 Form 10-Q Financial Statement

#000156459018012420 Filed on May 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $165.0K $148.0K
YoY Change 11.49% -84.29%
Cost Of Revenue $205.0K
YoY Change
Gross Profit -$40.00K
YoY Change
Gross Profit Margin -24.24%
Selling, General & Admin $16.89M $6.472M
YoY Change 160.99% -12.89%
% of Gross Profit
Research & Development $18.97M $16.35M
YoY Change 16.06% -18.55%
% of Gross Profit
Depreciation & Amortization $3.240M $790.0K
YoY Change 310.13% 97.5%
% of Gross Profit
Operating Expenses $38.48M $25.60M
YoY Change 50.31% -9.34%
Operating Profit -$38.31M -$25.45M
YoY Change 50.53% -6.75%
Interest Expense $1.161M $150.0K
YoY Change 674.0% -34.78%
% of Operating Profit
Other Income/Expense, Net -$223.0K $20.00K
YoY Change -1215.0% -56.52%
Pretax Income -$38.96M -$25.29M
YoY Change 54.05% -6.4%
Income Tax
% Of Pretax Income
Net Earnings -$38.96M -$25.29M
YoY Change 54.06% -6.42%
Net Earnings / Revenue -23610.91% -17085.81%
Basic Earnings Per Share
Diluted Earnings Per Share -$631.0K -$604.6K
COMMON SHARES
Basic Shares Outstanding 44.35M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $250.8M $85.40M
YoY Change 193.68% -48.8%
Cash & Equivalents $36.07M $21.47M
Short-Term Investments $214.7M $63.90M
Other Short-Term Assets $3.300M $2.800M
YoY Change 17.86% 3.7%
Inventory $550.0K
Prepaid Expenses
Receivables $800.0K $1.500M
Other Receivables $0.00 $0.00
Total Short-Term Assets $255.4M $89.70M
YoY Change 184.72% -47.45%
LONG-TERM ASSETS
Property, Plant & Equipment $17.06M $16.60M
YoY Change 2.8% 4.4%
Goodwill
YoY Change
Intangibles $18.66M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.900M $1.800M
YoY Change 5.56% 100.0%
Total Long-Term Assets $39.90M $20.40M
YoY Change 95.61% 7.94%
TOTAL ASSETS
Total Short-Term Assets $255.4M $89.70M
Total Long-Term Assets $39.90M $20.40M
Total Assets $295.3M $110.1M
YoY Change 168.21% -41.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.300M $1.500M
YoY Change 53.33% -57.14%
Accrued Expenses $14.30M $10.90M
YoY Change 31.19% -43.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.50M $12.40M
YoY Change 89.52% -49.39%
LONG-TERM LIABILITIES
Long-Term Debt $99.20M $0.00
YoY Change
Other Long-Term Liabilities $6.700M $358.0K
YoY Change 1771.51% -48.86%
Total Long-Term Liabilities $105.9M $358.0K
YoY Change 29481.01% -48.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.50M $12.40M
Total Long-Term Liabilities $105.9M $358.0K
Total Liabilities $129.4M $12.74M
YoY Change 916.02% -49.46%
SHAREHOLDERS EQUITY
Retained Earnings -$837.5M
YoY Change 15.23%
Common Stock $938.2M
YoY Change 5.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $165.9M $97.40M
YoY Change
Total Liabilities & Shareholders Equity $295.3M $110.1M
YoY Change 168.13% -41.93%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$38.96M -$25.29M
YoY Change 54.06% -6.42%
Depreciation, Depletion And Amortization $3.240M $790.0K
YoY Change 310.13% 97.5%
Cash From Operating Activities -$29.87M -$25.25M
YoY Change 18.3% -6.93%
INVESTING ACTIVITIES
Capital Expenditures $897.0K $234.0K
YoY Change 283.33% -91.04%
Acquisitions
YoY Change
Other Investing Activities -$49.29M -$6.780M
YoY Change 626.99% -129.02%
Cash From Investing Activities -$59.69M -$7.010M
YoY Change 751.43% -133.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $29.54M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 98.83M 29.39M
YoY Change 236.27% 8544.12%
NET CHANGE
Cash From Operating Activities -29.87M -25.25M
Cash From Investing Activities -59.69M -7.010M
Cash From Financing Activities 98.83M 29.39M
Net Change In Cash 9.489M -2.814M
YoY Change -437.21% -53.41%
FREE CASH FLOW
Cash From Operating Activities -$29.87M -$25.25M
Capital Expenditures $897.0K $234.0K
Free Cash Flow -$30.77M -$25.48M
YoY Change 20.74% -14.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18662000
CY2018Q1 us-gaap Inventory Net
InventoryNet
550000
CY2017Q4 us-gaap Inventory Net
InventoryNet
312000
CY2017Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
1306000
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3303000
CY2018Q1 us-gaap Assets Current
AssetsCurrent
255396000
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17064000
CY2018Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
165000
CY2018Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
205000
CY2018Q1 us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
2417000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16891000
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6472000
CY2017Q1 us-gaap Restructuring Charges
RestructuringCharges
2783000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
38479000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
25600000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-38314000
CY2018Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7000000
CY2018Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-25452000
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
740000
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
145000
CY2018Q1 us-gaap Interest Expense
InterestExpense
1161000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-223000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-38958000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-25287000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.63
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61744000
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41830000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-22000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-29000
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
690000
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
303000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
668000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
274000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38290000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25013000
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
823000
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
789000
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
21000
CY2018Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
176000
CY2017Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
10000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3821000
CY2018Q1 dvax Non Cash Interest Expense
NonCashInterestExpense
348000
CY2018Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-91000
CY2017Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
123000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
238000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-394000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
39000
CY2018Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3000
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
907000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
349000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2110000
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
276000
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1363000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-29872000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-25250000
CY2018Q1 dvax Payments To Acquire Technology Licenses
PaymentsToAcquireTechnologyLicenses
9500000
CY2018Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
141103000
CY2017Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
44652000
CY2018Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
91815000
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
37875000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
897000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
234000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-59685000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7011000
CY2018Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
99000000
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29535000
CY2018Q1 dvax Tax Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
TaxWithholdingsProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
-426000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
29387000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4799000
CY2018Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
250881000
CY2018Q1 us-gaap Interest Paid
InterestPaid
813000
CY2017Q1 dvax Release Of Accrual For Litigation Settlement And Insurance Recovery
ReleaseOfAccrualForLitigationSettlementAndInsuranceRecovery
4050000
CY2018Q1 dvax Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
37000
CY2017Q1 dvax Tax Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
TaxWithholdingsProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
-303000
CY2018Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
255000
CY2017Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
155000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
98829000
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217000
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9489000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2814000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27213000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24891000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36702000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22077000
CY2018Q1 dvax Noncash Or Part Noncash Acquisition Of Technology License
NoncashOrPartNoncashAcquisitionOfTechnologyLicense
12773000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3555000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1807000
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5030000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2462000
CY2017Q4 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
19.56
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.81
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.67
CY2018Q1 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
18.47
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
18.56
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.55
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M4D
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y1M13D
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M9D
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15064000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
14156000
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4985000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21472000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24289000
CY2017Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
605000
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Management&#8217;s estimates are based on historical information available as of the date of the condensed consolidated financial statements and various other assumptions we believe are reasonable under the circumstances. Actual results could differ materially from these estimates.</p></div>
CY2018Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
250800000
CY2018Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q1 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
CY2018Q1 us-gaap Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
0
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
602000
CY2018Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
107000
CY2018Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
250780000
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
312000
CY2018Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
550000
CY2018Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22273000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2500000
CY2018Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3611000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1194000
CY2018Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18662000
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1306000
CY2017Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2017Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
600000
CY2018Q1 dvax Amount Available For Borrowing Under Long Term Debt Agreement
AmountAvailableForBorrowingUnderLongTermDebtAgreement
175000000
CY2018Q1 dvax Secured Long Term Debt Noncurrent Plus Interest In Kind
SecuredLongTermDebtNoncurrentPlusInterestInKind
100200000
CY2018Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-12-31
CY2018Q1 us-gaap Loss Contingency Settlement Agreement Date
LossContingencySettlementAgreementDate
September 7, 2016
CY2018Q1 dvax Product Revenue Allowance And Reserves Classified As Reduction In Accounts Receivable
ProductRevenueAllowanceAndReservesClassifiedAsReductionInAccountsReceivable
66000
CY2018Q1 dvax Product Revenue Allowance And Reserves Classified As Accrued Liabilities
ProductRevenueAllowanceAndReservesClassifiedAsAccruedLiabilities
19000
CY2018Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2017Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5307000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3821000
CY2017Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.40

Files In Submission

Name View Source Status
0001564590-18-012420-index-headers.html Edgar Link pending
0001564590-18-012420-index.html Edgar Link pending
0001564590-18-012420.txt Edgar Link pending
0001564590-18-012420-xbrl.zip Edgar Link pending
dvax-10q_20180331.htm Edgar Link pending
dvax-20180331.xml Edgar Link completed
dvax-20180331.xsd Edgar Link pending
dvax-20180331_cal.xml Edgar Link unprocessable
dvax-20180331_def.xml Edgar Link unprocessable
dvax-20180331_lab.xml Edgar Link unprocessable
dvax-20180331_pre.xml Edgar Link unprocessable
dvax-ex101_596.htm Edgar Link pending
dvax-ex102_691.htm Edgar Link pending
dvax-ex103_466.htm Edgar Link pending
dvax-ex311_7.htm Edgar Link pending
dvax-ex312_10.htm Edgar Link pending
dvax-ex321_8.htm Edgar Link pending
dvax-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending